
About IVDIA
IVDIA is a Healthcare company based in Jaipur (India). Functions as a CDMO specializing in pharmaceutical manufacturing and validation. It operates on a B2B model. Its Indian entity Reagent Ivd Resources Private Limited reported revenue of βΉ2.46 Cr. Its focus areas include Pharmaceuticals, Manufacturing and Validation Services.
Company details
IVDIA operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and validation services. Functions as a CDMO specializing in pharmaceutical manufacturing and validation. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Jaipur, India
- SectorsHealthcare
- Website ivdia.co
- Legal Name Reagent Ivd Resources Private Limited
- Date of Incorporation 11 Jul, 2017
- Jurisdiction Jaipur, Rajasthan, India
- Annual Revenue₹2.46 Cr
FY 2025 · +3% YoY
- Net Loss-₹7.6 Lakh
FY 2025 · -3% margin
- EBITDA₹17.4 Lakh
FY 2025 · 7% margin
Associated legal entities of IVDIA
IVDIA operates through Reagent Ivd Resources Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Reagent Ivd Resources Private Limited CIN U74999RJ2017PTC058535 | Active | 11 Jul 2017 | Jaipur, Rajasthan | ₹2.5 Cr | 3 | View details |
Board of directors of Reagent Ivd Resources Private Limited (IVDIA)
Reagent Ivd Resources Private Limited is the primary company behind IVDIA. The board of Reagent Ivd Resources Private Limited currently have 3 directors; the longest-serving is Madhur Mohan Goyal, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Madhur Mohan Goyal DIN 07004495 | Director | 11 Jul 2017 | 9 yrs 3 mo | Reagent Ivd Resources Private Limited |
| Rashee Mittal DIN 06556041 | Director | 11 Jul 2017 | 9 yrs 3 mo | Reagent Ivd Resources Private Limited |
| Sanjeev Kumar Gupta DIN 09037945 | Director | 18 Oct 2022 | 4 yrs | Reagent Ivd Resources Private Limited |
Financials of IVDIA
Figures of Reagent Ivd Resources Private Limited, the primary company behind IVDIA, for FY 2025. Revenue was ₹2.46 Cr (+3% year on year). Net loss was -₹7.6 Lakh (-3% margin). EBITDA was ₹17.4 Lakh (7% margin). Revenue has grown at a compounded annual rate of +2% over three years and +13% over five years.
- ₹2.46 CrRevenue · FY 2025 · +3% YoY
- -₹7.6 LakhNet loss · -3% margin
- ₹17.4 LakhEBITDA · 7% margin
- ₹1 LakhPaid-up capital
- +2%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Reagent Ivd Resources Private Limited are on its company page.
Detailed financial statements for IVDIA
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ivdia
Complete news archive for IVDIA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IVDIA
IVDIA is headquartered in Jaipur, India. It is registered at Jaipur, Rajasthan, India.
The primary company behind IVDIA, Reagent Ivd Resources Private Limited, reported revenue of βΉ2.46 Cr for FY 2025, up 3% year on year.
IVDIA operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and validation services. Functions as a CDMO specializing in pharmaceutical manufacturing and validation. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
IVDIA operates through Reagent Ivd Resources Private Limited.
The legal entities of IVDIA currently have 3 directors, including Sanjeev Kumar Gupta, Madhur Mohan Goyal, Rashee Mittal.
